← Back to Search

Procedure

LASIK vs ICL for Near-sightedness (EVOlve Trial)

N/A
Waitlist Available
Research Sponsored by Vance Thompson Vision
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects ages 21 to 45 years old
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
No Placebo-Only Group

Summary

"This trial is comparing the results of implantable contact lenses (ICLs) versus LASIK surgery for correcting or reducing nearsightedness with or without astigmatism in both eyes."

Who is the study for?
This trial is for individuals with near-sightedness, possibly also having astigmatism, who are seeking vision correction. Specific eligibility criteria details were not provided.
What is being tested?
The study compares two types of vision correction procedures: LASIK, a laser surgery reshaping the cornea; and EVO-ICL placement, where a lens is implanted inside the eye.
What are the potential side effects?
Potential side effects for LASIK may include dry eyes, glare, halos around lights or double vision. EVO-ICL risks could involve cataracts, increased eye pressure or infection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 21 and 45 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Abberometry (Higher Order Abberations and Corneal Performance Index)
Contrast Sensitivity
Manifest refractive spherical equivalent
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Implantable Collamer Lens placementActive Control1 Intervention
EVO ICL
Group II: Laser-assisted in Situ KeratomileusisActive Control1 Intervention
LASIK-Wavefront Optimized

Find a Location

Who is running the clinical trial?

Vance Thompson VisionLead Sponsor
10 Previous Clinical Trials
244 Total Patients Enrolled
~37 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top